Management of puberty for optimal auxological results in β-thalassaemia major

Journal of Pediatric Endocrinology and Metabolism

Volumn 14, Issue SUPPL. 2, 2001, Pages 939-944

  Caruso Nicoletti, M ^a   De Sanctis, V ^a   Cavallo, L ^a   Raiola, G ^a   Ruggiero, L ^a   Skordis, N ^a   Wonke, B ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Consensus guidelines; Growth; Hypogonadism; Puberty; Short stature; Short trunk; Thalassaemia

Indexed keywords

ASCORBIC ACID; CHORIONIC GONADOTROPIN; DEFERIPRONE; DEFEROXAMINE; ETHINYLESTRADIOL; FERRITIN; FOLLITROPIN; GROWTH HORMONE; IRON; IRON CHELATING AGENT; SEX HORMONE; SOMATOMEDIN C; TESTOSTERONE;

ADOLESCENT; ARTICLE; BLOOD TRANSFUSION; CHILD; CHILD GROWTH; CHILDHOOD; CLINICAL FEATURE; DECELERATION; ENDOCRINE DISEASE; FEMALE; GROWTH ACCELERATION; GROWTH DISORDER; GROWTH RATE; HUMAN; HYPOGONADISM; IRON OVERLOAD; MALE; PRACTICE GUIDELINE; PUBERTY DISORDERS; SHORT STATURE; SPLENECTOMY; THALASSEMIA MAJOR; TRUNK;

EID: 0034884847     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/jpem-2001-s205     Document Type: Article

References (28)

1. Transfusion therapy in Cooley's anemia, growth and health as related to long-range hemoglobin levels. A progress report
2. Survival and desferrioxamine in thalassemia major
3. Growth and sexual maturation in thalassemia major
4. Growth in thalassemia major
5. Endocrine abnormalities in thalassemia major
6. Body growth in Cooley's anemia in relation to hemoglobin and ferritin levels
7. Studies in desferrioxamine and ferrioxamine metabolism in normal and iron-loaded subjects
8. Studies of variation of subcutaneously infused desferrioxamine and iron movements in thalassemia children
9. Desferrioxamine-induced growth retardation in patients with thalassemia major
10. Desferrioxamine induced bone dysplasia in patients with thalassemia major
11. Growth failure and body changes induced by desferrioxamine
12. Long-term follow-up of skeletal dysplasia in thalassemia major
13. Growth and development in thalassemia major patients with severe bone lesions due to desferrioxamine
14. Growth and development in children with thalassemia major
15. Growth in homozygous β-thalassemia
16. Short stature and body proportion in thalassemia
17. Endocrine function in thalassemia major
18. Gonadotropin insufficiency in patients with thalassemia major
19. Multicentre study on prevalence of endocrine complications in thalassemia major
20. Proposte di linee guida per la diagnosi e il trattamento delle complicanze endocrine nel paziente talassemico
21. Hormonal replacement therapy with HCG and HUFSH in thalassemic patients affected by hypogonadotropic hypogonadism
22. Depressed serum somatomedin activity in beta-thalassemia
23. Impaired growth hormone (GH) response to GH-releasing hormone in thalassemia major
24. GH secretion in thalassemic patients with short stature
25. Growth deficiency in polytransfused β-thalassemia patients is not growth hormone dependent
26. Short stature and failure of pubertal development in thalassemia major: Evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion
27. Short-term therapy with recombinant growth hormone in polytransfused thalassemia major patients with growth deficiency
28. Growth hormone treatment of short Chinese children with β-thalassemia major without GH deficiency